U.S. National Institutes Of Health Leader Stands Behind Psychedelic Medicines and Cannabis Therapies
WASHINGTON, D.C.–The National Institutes of Health (NIH), is the leading health organization in the U.S.A., Dr. Francis Collins, (who Dr. Anthony Fauci works for) praised the potential of psychedelic research during a U.S. Senate budget hearing last week in Washington D.C.
Collins launded the progress in psilocybin research, which has been tested in clinical trials for depression in the U.S.
“That could be quite exciting, because we all are looking for new approaches to that,” he said, adding that MDMA and LSD are also of interest.
On the topic of cannabis and greater access to the plant for researchers, Collins said “We’re making some progress.”
“What we really need is to moderate the Schedule 1 limitation,” Collins said, adding that he’s discussed the possibility of creating a new category, Schedule I-R, that could create further pathways for research.
(Reporting from The Vancouver Sun and The Growth Op and Other Sources. Image: Getty Images License)
California Cannabis Brand, Rose, Teams Up with Kiva Sales and Service to Expand Product Line
LOS ANGELES-- Rose, California's cannabis brand, announced today an exclusive partnership with Kiva Sales and Service (KSS), a top sales and distribution platform that offers dispensaries a curated selection of the best brands in the ...
Australian Nurses Call for Medicinal Cannabis Education in Undergraduate Degrees
The group wants education about the endocannabinoid system included in undergraduate nursing degrees. Seven years ago, the Federal Parliament passed legislation to legalise medicinal cannabis in Australia. Since then, most cannabis medications have been classified ...
Psychedelic Firm Reunion Neuroscience Sues Mindset Pharma for Patent Infringement and Breach of Contract
LOS ANGELES-- Clinical research firm Reunion Neuroscience Inc. has filed a lawsuit against Mindset Pharma Inc. in federal court, alleging that the latter copied its psychedelic formula and presented it as its own invention while ...